Flurbiprofen
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Flurbiprofen is used to treat rheumatoid arthritis, inflammation, macular edema, miosis and osteoarthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 31, 1988, and the first generic was approved Jun 20, 1994. In 2024, Medicare Part D spent $631K on Flurbiprofen across 16,000 claims for 6,802 beneficiaries.
Flurbiprofen is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $3.17 to $3.17 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$3.17 – $3.17
per EA
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Genus Lifesciences Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonsteroidal Anti-inflammatory Drug class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing FLURBIPROFEN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FLURBIPROFEN 100 MG TABLET | $3.1734 per EA | -0.01% |
LURBIRO 100 MG TABLET | $3.1734 per EA | -0.01% |
Frequently Asked Questions
What is Flurbiprofen used to treat?
Flurbiprofen is used to treat rheumatoid arthritis, inflammation, macular edema, miosis and osteoarthritis, per the National Library of Medicine's MED-RT classification.
When did Flurbiprofen become available as a generic?
FDA approved the first generic Flurbiprofen (ANDA) on Jun 20, 1994.
How much does Medicare spend on Flurbiprofen?
In 2024, Medicare Part D spent $631K on Flurbiprofen across 16,000 claims for 6,802 beneficiaries.
How many Flurbiprofen products are on the market?
The Flurbiprofen drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Flurbiprofen?
NADAC reference prices for Flurbiprofen range from $3.1734 to $3.1734 per EA.
Which manufacturers make Flurbiprofen?
2 manufacturers list Flurbiprofen in NADAC. Ranked by number of NDCs, the largest are Genus Lifesciences Inc. (1), IPG Pharmaceuticals, Inc. (1).
How has the price of Flurbiprofen changed recently?
Over the past 7 days, 0 Flurbiprofen NDCs rose and 2 fell, with a market-wide average change of -0.0%.